A Prospective Randomized Controlled Trial Evaluating the Impact of Uterine Manipulator Use During Total Abdominal Hysterectomy on Postoperative Female Sexual Function

What this Trial Is About

Researchers are conducting a prospective, single-center, randomized controlled trial to assess how using a uterine manipulator during total abdominal hysterectomy affects female sexual function three months after surgery. The study focuses on women undergoing hysterectomy for benign conditions such as uterine fibroids, adenomyoma, or uterine bleeding. The main goal is to measure postoperative sexual function using the Female Sexual Function Index (FSFI). Participants are randomly assigned to one of two groups: one group undergoes total abdominal hysterectomy with a uterine manipulator, and the other group undergoes the same surgery without the manipulator. Both procedures are performed under double masking to reduce bias. The trial also examines secondary outcomes including operative time, changes in hemoglobin levels, postoperative pain at several time points, length of hospital stay, and complications occurring within 30 days after surgery. During the study, participants will complete the FSFI questionnaire three months after surgery to assess sexual function. Researchers will monitor operative details during surgery and assess pain levels using a visual analog scale at 6, 12, and 24 hours postoperatively. Hemoglobin levels will be measured at similar time points. Hospital stay duration and any complications within 30 days after surgery will be recorded. The entire participation focuses on these assessments to evaluate the impact of the uterine manipulator on recovery and sexual health.

The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function